TCL Archive Iressa Authorization In Europe Clarifies Differences Between U.S., E.U. Standards July 31, 2009
TCL Archive Nobel Laureate Gilman Prepares to Leave The Texas Cancer Agency—Can it Survive? September 28, 2012
TCL Archive Growth in Research Capacity Explains Increased Competition, NIH Director Tells NCAB. June 16, 2006
TCL Archive Drug Cleared For GIST And Kidney Cancer, FDA’s First Two-Indication Cancer Approval January 27, 2006
TCL Archive DCPC Begins Reassessment of Year 2000 Goals; Advisors Discuss A ‘More Dynamic Model’ May 22, 1992
